UnitedHealth Group Incorporated (UNH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
UnitedHealth Group Incorporated (UNH) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. Cash-backed 11% return on capital boosted by $1.37B (36C10G24K0111) in obligated U.S. government contracts. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
How UNH Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $447.57B | 88.7% | 4.2% | $12.06B | $16.07B | 9.8% |
| FY 2024 | $400.28B | 88.3% | 8.1% | $14.40B | $20.70B | 17.1% |
| FY 2023 | $371.62B | 89.6% | 8.7% | $22.38B | $25.68B | 19.6% |
| FY 2022 | $324.16B | 89.6% | 8.8% | $20.12B | $23.40B | 19.6% |
| FY 2021 | $287.60B | 89.2% | 8.3% | $17.29B | $19.89B | 19.3% |
| FY 2020 | $257.14B | 88% | 8.7% | $15.40B | $20.12B | 18.9% |
UnitedHealth Group's FY2025 Form 10-K (accession 0000731766-26-000062) signals operational friction and top-line slowdown across its high-margin analytics franchise, evidenced by a $1.7B contraction in total Optum Insight backlog and an explicit $1.5B drop in 12-month expected realization. Concurrently, management discloses an unheralded 2026 business realignment alongside condensed risk-transfer disclosures in commercial benefits, indicating internal restructuring pressures to defend margins against elevated medical loss ratios and heightened regulatory scrutiny across Medicare Advantage and payment integrity operations.
Optum Insight's contract backlog fell by 5.2% year-over-year while near-term 12-month convertible revenue dropped $1.5B (7.6%). This marks a material structural deterioration in external payer and provider software/services demand, pointing to decelerating growth and customer churn in UNH's highest-margin technology segment following regulatory pushback against automated payment integrity workflows.
Management quietly instituted a segment resegmentation effective Q1 2026. Historically, mid-stream business reorganizations at managed care conglomerates obscure underperforming business lines, shift overhead allocations away from high-scrutiny Optum units, and reset comparative historical baselines ahead of Medicare Advantage risk-adjustment regulatory audits.
The registrant stripped out granular descriptions of administrative facilitation, network fee extraction, and risk demarcation between fee-for-service administration and balance-sheet risk-based insurance. This streamlines legal liability disclosures as self-insured employer sponsors face increasing ERISA fiduciary litigation over excessive PBM and administrative processing spreads.
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring UNH)
- ✓Live walkthrough of UNH's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
UNH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.
vs. +6.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on UNH today. View full Setup Ledger →
UNH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is UnitedHealth Group Incorporated (UNH)?
In FY 2025 (10-K), UNH converted $447.6B of revenue into a 88.7% gross margin, 4.2% operating margin, and $16.1B in free cash flow (3.6% FCF margin).